X
Pharma Advancement
  • Home
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development

    NHS Acquires Potentially Lifesaving Breast Cancer Medication

    Transfusion of The First Patients Lab-Grown Blood Cells

    Bispecific Cancer Drugs, Gene Therapy Advances At Next ASH

    First Virtual Drug Study Tests 2 Likely Alzheimer Therapies

    First Virtual Drug Study Tests 2 Likely Alzheimer Therapies

    $2 Million Gene Therapy Might Become The Standard In The US

    $2 Million Gene Therapy Might Become The Standard In The US

    Cancer Medicine Prices Jump 53% In Five Years In The U.S

    Food And Drug Administration User Fee Has Been Reauthorized

    Cancer Clinical Trials Get A Brand New Platform In Melbourne

    Report Indicates UK £62bn Behind In Global R&D Investment

    Report Indicates UK £62bn Behind In Global R&D Investment

  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development

    NHS Acquires Potentially Lifesaving Breast Cancer Medication

    Transfusion of The First Patients Lab-Grown Blood Cells

    Bispecific Cancer Drugs, Gene Therapy Advances At Next ASH

    First Virtual Drug Study Tests 2 Likely Alzheimer Therapies

    First Virtual Drug Study Tests 2 Likely Alzheimer Therapies

    $2 Million Gene Therapy Might Become The Standard In The US

    $2 Million Gene Therapy Might Become The Standard In The US

    Cancer Medicine Prices Jump 53% In Five Years In The U.S

    Food And Drug Administration User Fee Has Been Reauthorized

    Cancer Clinical Trials Get A Brand New Platform In Melbourne

    Report Indicates UK £62bn Behind In Global R&D Investment

    Report Indicates UK £62bn Behind In Global R&D Investment

  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home Facilities & Operation

UPDATE 3-Drug maker Novo Nordisk to build $78 mln plant in Iran

Yuvraj_pawp by Yuvraj_pawp
5th October 2015
in Facilities & Operation

Danish drug maker Novo Nordisk will invest 70 million euros ($78 million) to build a manufacturing plant in Iran, joining a small group of European companies to announce concrete deals there since the Islamic Republic reached a nuclear deal in July.

Novo Nordisk, the world’s largest diabetes drugs maker, has had a subsidiary in the country since 2005 selling insulin and employing 130 people.

But the plant “signals our long-term commitment to Iran”, the Danish company said in a statement.

“We have been working on this for a long time, also before the nuclear agreement was settled, and we have confidence that the Iranian society and economy is developing positively,” Ole Moelskov Bech, head of the firm’s Near East unit, told Reuters.

Construction is expected to begin in six months’ time, the company said.

The medicinal sector has escaped U.S., European Union and United Nations sanctions, which have focused on industries that could be related to nuclear activity as well as on banking, technology and oil.

But the restrictions have nevertheless made doing business in Iran tricky, Bech said.

“Even though the medicine industry was never abandoned in Iran (by foreign businesses), the sanctions have been making it all much more difficult as a lot of rules needed to be followed, on information technology and banking, which made it necessary to have individual systems for Iran,” Bech told Reuters.

Novo Nordisk has not been able to use the same IT platforms as in the rest of the business, forcing the company to spend time on work-around solutions, Bech said.

Several European ministers have visited Iran with businesses in tow since it struck the deal with six world powers in July under which it must curb sensitive aspects of its nuclear energy programme in exchange for a lifting of sanctions.

Earlier this month, Austrian companies signed deals worth 80 million euros with Iranian partners.

But most Western companies say they will wait until the nuclear agreement is implemented and sanctions removed before they make any firm business commitments in Iran.

Copenhagen Airport A/S said on Tuesday the first flights between Denmark and Iran would begin in March 2016, resuming a direct service between the capitals that had been suspended for eight years.($1 = 0.8950 euros) ($1 = 6.6867 Danish crowns)

Previous Post

Allergan Successfully Completes Kythera Acquisition; Adds Game-Changing KYBELLA Treatment for Double-Chin

Next Post

Hillary Clinton Proposes $250 Monthly Cap on Prescription Drug Costs

Related Posts

India Seeks Better Pharma Market Access In The UK: Official
Facilities & Operation

India Seeks Better Pharma Market Access In The UK: Official

8th November 2022
CPhI Pharma Index Shows Unprecedented Global Pharma Optimism
Facilities & Operation

CPhI Pharma Index Shows Unprecedented Global Pharma Optimism

5th November 2022
CPHI Report Says, Biologics Outsourcing Will Surge In 2023
Facilities & Operation

CPHI Report Says, Biologics Outsourcing Will Surge In 2023

28th October 2022
Facilities & Operation

Gates Foundation Commits $1.2 Billion To Root Out Polio

20th October 2022
Facilities & Operation

RNA Vaccine UK Innovation Centre At CPI Gets Fresh Funding

11th October 2022
Facilities & Operation

To Aid Keytruda And Gardasil, Merck Expands Singapore Hub

8th October 2022
Next Post

Hillary Clinton Proposes $250 Monthly Cap on Prescription Drug Costs

Latest News

FDA Approvals

NHS Acquires Potentially Lifesaving Breast Cancer Medication

9th November 2022
Clinical Trials

Transfusion of The First Patients Lab-Grown Blood Cells

9th November 2022
Clinical Trials

Bispecific Cancer Drugs, Gene Therapy Advances At Next ASH

8th November 2022
India Seeks Better Pharma Market Access In The UK: Official
Facilities & Operation

India Seeks Better Pharma Market Access In The UK: Official

8th November 2022
First Virtual Drug Study Tests 2 Likely Alzheimer Therapies
Clinical Trials

First Virtual Drug Study Tests 2 Likely Alzheimer Therapies

7th November 2022
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack

System

  • Search
  • Sitemap
  • RSS Feed

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In